JPRN-UMIN000001807已完成2 期
Efficacy and Safty of Long Acting Beraprost (TRK-100STP) for Lumbar Spinal Canal Stenosis with Intermittent Claudication :A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial - Phase2 exploratory study of TRK-100STP
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Patients who have any complication, which could affect efficacy assessments. (2)Patients who is bleeding or have a tendency to bleed. (3)Patients are allergic to beraprost sodium. (4)Patients have severe disorders. (5)Patients who determined the principal investigator or the sub-investigator to be inadequate to participate in the trial.
研究者
相似试验
已完成
2 期
Efficacy and Safty of Long Acting Beraprost (TRK-100STP) for Lumbar Spinal Canal Stenosis with Intermittent Claudication :A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcquired degenerative lumbar spinal canal stenosisJPRN-UMIN000005575KAKEN PHARMACEUTICAL CO., LTD150
招募中
不适用
Effects of beraprost sodium sustained-release tablet on improvement of insulin resistance in patients with type 2 diabetes with obesity in a Double-Blinded, Randomized, Placebo-Controlled, Crossover Trial.Patients with type 2 diabetes and obesityJPRN-UMIN000008469Graduate School of Medicine, University of Tokyo Department of Metabolic Diseases40
招募中
不适用
The study of effects of additional beraprost on the amelioration and retention of retinal and choroidal circulation after ranibizumab treatment in age-related macular degeneration.age-related macular degenerationJPRN-UMIN000006869agasaki university40
已完成
3 期
Efficacy and safety of bimatoprost 0.01% for the treatment of eyebrow hypotrichosis: A randomized, double-blind, vehicle-controlled studyEyebrow hypotrichosisMadarosisTCTR20160911001Division of Dermatology, Ramathibodi Hospital, Mahidol University40
进行中（未招募）
1 期
Evaluation of the tolerance and efficacy of Monoprost in patients with Glaucoma or Ocular Hypertension, stabilized with Lumigan with signs of ocular surface intoleranceglaucoma, ocular hypertensionMedDRA version: 16.0Level: HLGTClassification code 10018307Term: Glaucoma and ocular hypertensionSystem Organ Class: 10015919 - Eye disordersEUCTR2013-001250-10-ESaboratoires Thea396